TransMedics Group, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US89377M1099
USD
138.63
-3.14 (-2.21%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
157.37
143.54
121.62
108.76
114.31
96.85
81.17
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
157.37
143.54
121.62
108.76
114.31
96.85
81.17
Raw Material Cost
60.88
55.41
49.61
48.02
45.14
36.99
33.25
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.48
3.46
3.57
3.62
3.62
3.60
3.60
Selling and Distribution Expenses
43.99
43.52
46.91
42.56
42.80
36.06
34.56
Other Expenses
1.25
1.37
1.29
1.06
1.02
0.78
0.72
Total Expenditure (Excl Depreciation)
120.80
116.09
112.98
104.84
101.80
84.43
78.57
Operating Profit (PBDIT) excl Other Income
36.6
27.400000000000002
8.6
3.9000000000000004
12.5
12.4
2.6
Other Income
3.09
2.69
1.92
3.94
3.27
3.57
4.87
Operating Profit (PBDIT)
46.39
36.27
16.24
13.04
20.38
20.39
11.17
Interest
3.48
3.46
3.57
3.62
3.62
3.60
3.60
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
96.49
88.13
72.01
60.74
69.16
59.86
47.92
Depreciation
6.73
6.14
5.68
5.18
4.60
4.40
3.71
Profit Before Tax
36.18
26.68
6.99
4.25
12.15
12.39
3.86
Tax
1.27
0.99
0.13
0.03
-0.04
0.20
-0.17
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
34.91
25.68
6.86
4.22
12.19
12.20
4.03
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
34.91
25.68
6.86
4.22
12.19
12.20
4.03
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
34.91
25.68
6.86
4.22
12.19
12.20
4.03
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
318.10
266.31
228.60
209.92
189.89
159.47
137.20
Earnings per share (EPS)
0.92
0.7
0.19
0.12
0.35
0.35
0.12
Diluted Earnings per share
0.92
0.7
0.19
0.12
0.35
0.35
0.12
Operating Profit Margin (Excl OI)
23.24%
19.12%
7.11%
3.61%
10.94%
12.82%
3.21%
Gross Profit Margin
27.27%
22.86%
10.42%
8.66%
14.66%
17.34%
9.32%
PAT Margin
22.18%
17.89%
5.64%
3.88%
10.67%
12.59%
4.97%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is 37.71% vs 117.71% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is 186.07% vs 1,320.00% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is 153.22% vs 2,342.86% in Jun 2024

stock-summary

Interest

YoY Growth in quarter ended Jun 2025 is -2.78% vs 44.00% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024

Compare Quarterly Results Of TransMedics Group, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
157.37
44.32
113.05
255.08%
Other Operating Income
0.00
0.00
0.00
Total Operating income
157.37
44.32
113.05
255.08%
Raw Material Cost
60.88
12.72
48.16
378.62%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
3.48
0.00
3.48
Selling and Distribution Expenses
43.99
46.24
-2.25
-4.87%
Other Expenses
1.25
1.01
0.24
23.76%
Total Expenditure (Excl Depreciation)
120.80
69.04
51.76
74.97%
Operating Profit (PBDIT) excl Other Income
36.57
-24.72
61.29
247.94%
Other Income
3.09
4.05
-0.96
-23.70%
Operating Profit (PBDIT)
46.39
-18.69
65.08
348.21%
Interest
3.48
0.00
3.48
Exceptional Items
0.00
-5.25
5.25
100.00%
Gross Profit (PBDT)
96.49
31.60
64.89
205.35%
Depreciation
6.73
1.98
4.75
239.90%
Profit Before Tax
36.18
-25.91
62.09
239.64%
Tax
1.27
-9.10
10.37
113.96%
Provisions and contingencies
0
0
0.00
Profit After Tax
34.91
-16.81
51.72
307.67%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
34.91
-16.81
51.72
307.67%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
34.91
-16.81
51.72
307.67%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
318.10
336.57
-18.47
-5.49%
Earnings per share (EPS)
0.92
-0.34
1.26
370.59%
Diluted Earnings per share
0.92
-0.34
1.26
370.59%
Operating Profit Margin (Excl OI)
23.24%
-55.77%
0.00
79.01%
Gross Profit Margin
27.27%
-54.02%
0.00
81.29%
PAT Margin
22.18%
-37.93%
0.00
60.11%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 15.74 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 9.69% vs 18.01% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 37.71% vs 117.71% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 3.49 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 35.80% vs 272.46% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 186.07% vs 1,320.00% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.33 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 28.87% vs 134.97% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 153.22% vs 2,342.86% in Jun 2024

Quarterly - Interest
Interest 0.35 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 0.00% vs -2.78% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -2.78% vs 44.00% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.24%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024